Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Avanos Medical ( (AVNS) ) has shared an update.
Avanos Medical announced its participation in the 43rd Annual JP Morgan Healthcare Conference, highlighting strategic transformation initiatives aimed at optimizing their product portfolio and enhancing profitability. The company is focusing on market expansion through innovation, restructuring sales organizations, and cost management initiatives to drive growth and deliver value to stakeholders.
More about Avanos Medical
Avanos Medical is a company operating in the medical device industry, specializing in enteral feeding and pain management & recovery solutions. Their product portfolio includes renowned brands like CORTRAK*, TRIDENT*, and GAME READY*, and they focus on providing comprehensive nutrition systems and non-opioid pain management solutions.
YTD Price Performance: -3.98%
Average Trading Volume: 361,404
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $698.5M
See more insights into AVNS stock on TipRanks’ Stock Analysis page.
